How CIMZIA Works

In people with Crohn's disease, the immune system produces too much of a protein called TNF-alpha (tumor necrosis factor-alpha). TNF-alpha triggers inflammation, which can lead to painful, inconvenient symptoms and damage to your gastrointestinal (GI) tract.

CIMZIA is the only PEGylated anti-TNF, which enables dosing only once every 4 weeks after initial dosing.